why choose us

First received: November 17, 2022

Clinical Trial: ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Bladder Cancer

Study Type: OBSERVATIONAL


Official Title: Pilot Study to Evaluate the Role for Circulating Tumor DNA (ctDNA) in Monitoring Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

Brief Summary: The purpose of this prospective biospecimen collection study is to evaluate the feasibility of measuring circulating tumor DNA (ctDNA) in subjects with muscle-invasive bladder cancer (MIBC) treated with trimodality therapy consisting of a maximal transurethral resection of bladder tumor followed by radiation and concomitant chemotherapy.Cancer cells have unique genes that determine the characteristics of tumors, such as how they will respond to different treatments.The tumor tissue will be used to determine the…

Read more